UMeWorld Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that UMeWorld Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Sep 30, 2012 | $166.8K | Jan 16, 2013 |
| FY2012 | Sep 30, 2011 | $183.5K | Jan 16, 2013 |
| FY2011 | Sep 30, 2010 | $326.3K | Dec 9, 2011 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Sep 30, 2012 | ($77.3K) | Jan 16, 2013 |
| FY2012 | Sep 30, 2011 | ($262.1K) | Jan 16, 2013 |
| FY2011 | Sep 30, 2010 | ($751.8K) | Dec 9, 2011 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Sep 30, 2012 | ($240.3K) | Jan 16, 2013 |
| FY2012 | Sep 30, 2011 | ($241.5K) | Jan 16, 2013 |
| FY2011 | Sep 30, 2010 | ($659.7K) | Dec 9, 2011 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Sep 30, 2011 | $16.6K | Dec 9, 2011 |
| FY2011 | Sep 30, 2010 | $151.2K | Dec 9, 2011 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Sep 30, 2012 | ($21.41M) | Jan 16, 2013 |
| FY2012 | Sep 30, 2011 | $31.5K | Jan 16, 2013 |
| FY2011 | Sep 30, 2010 | ($385.7K) | Dec 9, 2011 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Sep 30, 2012 | $21.14M | Jan 16, 2013 |
| FY2012 | Sep 30, 2011 | $111.9K | Jan 16, 2013 |
| FY2011 | Sep 30, 2010 | $207.2K | Dec 9, 2011 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Sep 30, 2012 | $1.53M | Jan 16, 2013 |
| FY2012 | Sep 30, 2011 | $1.39M | Jan 16, 2013 |
| FY2011 | Sep 30, 2010 | $1.31M | Dec 9, 2011 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Sep 30, 2012 | $19.60M | Jan 16, 2013 |
| FY2012 | Sep 30, 2011 | ($1.28M) | Jan 16, 2013 |
| FY2011 | Sep 30, 2010 | ($1.10M) | Dec 9, 2011 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Sep 30, 2012 | ($19.12M) | Jan 16, 2013 |
| FY2012 | Sep 30, 2011 | ($19.05M) | Jan 16, 2013 |
| FY2011 | Sep 30, 2010 | ($18.79M) | Dec 9, 2011 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Sep 30, 2012 | $4.3K | Jan 16, 2013 |
| FY2012 | Sep 30, 2011 | $30.4K | Jan 16, 2013 |
| FY2012 | Sep 30, 2010 | $16.3K | Jan 16, 2013 |
| FY2011 | Sep 30, 2009 | $14.0K | Dec 9, 2011 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Sep 30, 2012 | 0 | Jan 16, 2013 |
| FY2012 | Sep 30, 2011 | 0 | Jan 16, 2013 |
| FY2011 | Sep 30, 2010 | 0 | Dec 9, 2011 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Sep 30, 2012 | 89.04M | Jan 16, 2013 |
| FY2012 | Sep 30, 2011 | 95.94M | Jan 16, 2013 |
| FY2011 | Sep 30, 2010 | 94.64M | Dec 9, 2011 |